✨ Your Portfolio is fetched and updated from zerodha.
Micro Agriculture

Nath Bio-Genes (India) Ltd.

NATHBIOGEN

Market Cap
₹302 Cr.
P/E
7.60

Nath Bio-Genes (India) Ltd.

  • Nath Bio-Genes
  • JK Agri Genetics
  • Shree Oswal Seeds
FAQs on Nath Bio-Genes (India) Ltd. Shareprice

Nath Bio-Genes has given lower returns compared to its competitors.
Nath Bio-Genes has grown at ~-12.6% over the last 3yrs while peers have grown at a median rate of 6.69%

Nath Bio-Genes is not expensive.
Latest PE of Nath Bio-Genes is 7.6, while 3 year average PE is 7.98.
Also latest EV/EBITDA of Nath Bio-Genes is 8.02 while 3yr average is 10.87.

View FAQ's On Business
Growth Table
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Balance Sheet
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Cash Flow
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Quarterly Results
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Nath Bio-Genes (India) Ltd. Financials

Balance sheet of Nath Bio-Genes is moderately strong.

Yes, The debt of Nath Bio-Genes is increasing.
Latest debt of Nath Bio-Genes is ₹125 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹44.45 Crs.

Yes, profit is increasing.
The profit of Nath Bio-Genes is ₹39.74 Crs for TTM, ₹39.62 Crs for Mar 2024 and ₹35.03 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Nath Bio-Genes latest dividend payout ratio is 9.59% and 3yr average dividend payout ratio is 10.22%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech